Pharma Equity faces court challenge to EUR 10.5 million arbitration award

PUBT · 22h ago
Pharma Equity faces court challenge to EUR 10.5 million arbitration award
  • Interpatium - Promoção Imobiliária filed suit in the Helsingør court seeking to set aside a June 12, 2026 arbitration award.
  • The award orders Interpatium to pay EUR 10.5 million, interest, costs.
  • Pharma Equity Group disputes the claim, plans to defend.
  • The court challenge does not automatically stay enforcement; PEG is continuing collection efforts under the award.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Equity Group A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609071043OMX_____CNEWS_DA_GNW1001261438_da) on September 07, 2026, and is solely responsible for the information contained therein.